AT1 Stock Overview
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Atomo Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.055 |
| 52 Week High | AU$0.23 |
| 52 Week Low | AU$0.053 |
| Beta | 0.96 |
| 1 Month Change | 1.85% |
| 3 Month Change | -9.84% |
| 1 Year Change | -74.42% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -85.90% |
Recent News & Updates
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Oct 10
Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?
Jun 10Recent updates
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Oct 10Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?
Jun 10We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn
Dec 06Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 01We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow
Jul 19Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)
Feb 26Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business
Jan 22Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like
Dec 18
When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?
Jul 16Shareholder Returns
| AT1 | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | 0.6% |
| 1Y | -74.4% | 2.2% | 3.5% |
Return vs Industry: AT1 underperformed the Australian Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: AT1 underperformed the Australian Market which returned 3.5% over the past year.
Price Volatility
| AT1 volatility | |
|---|---|
| AT1 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 9.7% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: AT1 is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: AT1's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | John Kelly | https://atomodiagnostics.com |
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Atomo Diagnostics Limited Fundamentals Summary
| AT1 fundamental statistics | |
|---|---|
| Market Cap | AU$31.40m |
| Earnings (TTM) | -AU$5.71m |
| Revenue (TTM) | AU$12.34m |
2.5x
P/S Ratio-5.5x
P/E RatioIs AT1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AT1 income statement (TTM) | |
|---|---|
| Revenue | AU$12.34m |
| Cost of Revenue | AU$8.45m |
| Gross Profit | AU$3.88m |
| Other Expenses | AU$9.59m |
| Earnings | -AU$5.71m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 31.48% |
| Net Profit Margin | -46.26% |
| Debt/Equity Ratio | 0% |
How did AT1 perform over the long term?
See historical performance and comparison